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Objective: The objectives of this observational cohort study were to investigate the prevalence of undiagnosed cognitive
impairment in older patients presenting for vascular surgery, to examine its association with adverse postoperative
outcomes, and to test the feasibility of a preoperative cognitive assessment tool.
Methods: Patients aged 60 years or older were recruited by consent on admission to the vascular surgical ward of an inner-
city teaching hospital with a large tertiary referral practice for proposed elective or emergency aortic or lower limb arterial
intervention. Cognition was assessed preoperatively by the Montreal Cognitive Assessment (MoCA), and a score below
24/30 indicated cognitive impairment or dementia. The mean length of time taken to complete the assessment was
recorded. Baseline characteristics (medical multimorbidity, frailty, and laboratory tests), hospital length of stay (LOS),
and postoperative complications were documented.
Results: Preoperative MoCA was completed in 114 patients with a mean age of 76.3 years (standard deviation, 7.36 years);
67.5% were men, and 55.3% of procedures were elective. The MoCA was completed in 100% of patients and was quick and
acceptable to patients in this setting. Cognitive impairment or dementia was found in 68% of patients (77 of 114) and was
previously unrecognized in 88.3% of patients (68 of 77). Therefore, 60.5% of patients (68 of 114) aged 60 years or older
presenting for vascular surgery had previously undiagnosed cognitive impairment. MoCA <24 was univariately associated
with pre-existing frailty (Edmonton Frail Scale [EFS] score $6.5) and longer LOS ($12 days). In logistic regression
modeling, MoCA <24 was strongly independently associated with frailty EFS score$6.5 (odds ratio, 12.55; P < .001). By
use of the area under the receiver operating characteristic curve (AUC), MoCA <24 was predictive of longer LOS of
$12 days (AUC, 0.621; P [ .049). The strength of predictive power increased with the addition of frailty (EFS score
$6.5) to the models (AUC, 0.695; P [ .002).
Conclusions: The prevalence of cognitive impairment among older patients presenting for vascular surgery is high and
frequently undiagnosed before admission. It is feasible to use the MoCA to identify cognitive impairment in this high-risk
surgical group preoperatively. The combined assessment of frailty and cognition is predictive of adverse postoperative
outcomes and longer LOS. (J Vasc Surg 2014;60:1002-11.)The aging population together with surgical and anes-
thetic advances has resulted in increased numbers of older
people having vascular procedures.1 Whereas older patients
beneﬁt from vascular surgical procedures,2 they remain at
higher risk than younger patients of adverse postoperative
outcomes.3 These adverse outcomes include mortality
and medical morbidity,4 such as delirium,5 and require
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2Cognitive impairment predominates in the older
population and can have a negative impact on postoperative
outcomes. Patients with cognitive impairment are at
increased risk of postoperative delirium6 and protracted
hospital length of stay (LOS) compared with the general
hospital population.7 Studies examining preoperative cogni-
tion with a neuropsychological test battery in older patients
undergoing elective orthopedic surgery found amnestic
mild cognitive impairment in 22%,8 and 44% of elective
abdominal and cardiothoracic surgery patients scored #3
on a preoperative Mini-Cog assessment.9 However, the
underlying disease and risk factors leading to orthopedic
and abdominal surgery are not risk factors for cognitive prob-
lems. In comparison, risk factors for peripheral vascular disease
(such as hypertension, hypercholesterolemia, and smoking)
predispose to vascular cognitive impairment10,11 and are inde-
pendently associated with postoperative delirium.5,12,13
Identifying a cognitive assessment tool that is robust
clinically for elective and emergency patients and for
research purposes is important, as neither a full neurocog-
nitive battery nor brief screening tools conform neatly to
both requirements. The Montreal Cognitive Assessment
(MoCA) is a 30-point assessment (Fig 1) that can be
completed in 10 minutes; within a mixed study cohort of
Fig 1. The Montreal Cognitive Assessment tool (MoCA). (Reproduced with permission from Nasreddine ZS, Phillips
NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief
screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9.)
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mentia, and community-dwelling controls, it shows high
retest reliability (correlation coefﬁcient, 0.92; P < .001)
and internal consistency (Cronbach a, .83).14 Sensitivity
and speciﬁcity are superior to the Mini-Mental State Exam-
ination,15 which until recently has been the short cognitive
assessment of choice.16,17 MoCA has been well validated in
the identiﬁcation of vascular cognitive impairment,18
vascular dementia,19 and mild cognitive impairment in pa-
tients with cardiovascular disease including heart failure20
and in those with neurodegenerative conditions including
Parkinson disease.21 However, there is no literature
describing the use of MoCA in the preoperative setting.
The aims of this study were to examine whether cogni-
tive assessment with a short bedside assessment tool
(MoCA) is clinically feasible within an older preoperative
inpatient surgical population; to measure the proportion
of older patients presenting for vascular surgery who have
undiagnosed cognitive impairment; and to examine
whether cognitive impairment, deﬁned by MoCA score,
is associated with a longer length of hospital stay.
METHODS
Ethical approval for the study was given in February
2011 by the South East Research Ethics Committee
(11/H1102/10).
Setting
The study was conducted at an inner-city teaching hos-
pital with a large tertiary referral practice for vascular surgery.
Subjects
Criteria for eligibility. Criteria for eligibility included
age of 60 years or older in a patient presenting for elective
or emergency aortic or lower limb arterial intervention.
Exclusion criteria. Patients receiving palliative treat-
ment for a terminal condition were excluded, as were
patients admitted and discharged over the weekend
(because of unavailability of the researcher at this time).
Recruitment and consent. Patients were recruited
within 48 hours of admission to the vascular surgical
unit. Those without capacity to consent were handled ac-
cording to sections 30-34 of the Mental Capacity Act
(2005) employing the use of a personal consultee to give
assent to study participation on behalf of the patient. The
ﬂow chart (Fig 2) shows details of patient recruitment.
Preoperative data collection
Baseline demographic data were collected through a
combination of patient interview and review of clinical re-
cords. Comorbidities and medications were recorded.
Frailty was assessed by the Edmonton Frail Scale (EFS),22
deﬁned by a cutoff score of $6.5/17.23 Preoperative func-
tional status was assessed by “timed up and go”
[TUAG],24 gait speed,25 and grip strength recorded with
a Jamar dynamometer, adhering to the standardized proto-
col recommended by the American Society of Hand Ther-
apists.26 TUAG was dichotomized at 20 seconds.27,28 Gaitspeed was dichotomized at 0.6 m/s.25,29,30 Hand grip
strength was compared with accepted age and gender no-
mograms.31 Anxiety and depression were assessed with
the Hospital Anxiety and Depression Scale.32
Cognitive assessment
Clinical researchers assessed patients by the MoCA.
Given the constraints of an acute surgical ward, all attempts
were made to perform the assessment in a calm, quiet envi-
ronment without interruption.
In addition, patients (and their carers or relatives) were
asked if a diagnosis of dementia or any “memory prob-
lems” had been noted before. The clinical notes including
correspondence were interrogated for any prior diagnosis
or mention of cognitive impairment or dementia.
In-hospital data collection
Outcome measures including process indicators
(LOS), postoperative morbidity (medical and surgical com-
plications), postoperative functional status (assessed by
TUAG and gait speed), and in-hospital mortality were
recorded contemporaneously from the clinical record.
Delirium was diagnosed by a researcher according to the
Confusion Assessment Method.33 Assessment for delirium
was undertaken daily except on weekends. LOS $12 days
was the mean LOS within this sample (which, as expected,
was skewed) and was chosen as the cut point because it rep-
resented a signiﬁcant resource use in terms of ﬁnancial cost.
Feasibility of cognitive assessment
In a subgroup of 46 patients, the time taken to preoper-
atively complete the MoCA was recorded in minutes. A sub-
set of 32 patients were reassessed cognitively with the
MoCA at between 6 weeks and 4 months after hospitaliza-
tion (mean of 73 days after hospital discharge). This conve-
nience sample consisted of those patients who were routinely
scheduled for and attended vascular outpatient clinics after
their surgery. This subset was also asked in a semistructured
manner for verbal feedback on their experience of the preop-
erative cognitive assessment undertaken as part of this study.
Data analysis
Data were analyzed by SPSS version 20 (IBM,
Armonk, NY). Univariate analyses were performed be-
tween cognitive impairment, deﬁned by a MoCA score
dichotomized at <24,20 and baseline and postoperative
variables. Multiple logistic regression models were used
to examine the strength of these associations with adjust-
ment for potential confounders. Clinically relevant and
statistically associated variables at the P < .05 level were
included in the models. To ensure that highly correlated
variables were not included in the regression models, vari-
ables were ﬁrst examined for strength of correlation. Vari-
ables with a Pearson coefﬁcient correlation of >0.6 were
not both included in the models; where this situation
arose, the variable of most clinical relevance was included.
The associations between LOS $12 days and baseline
variables and postoperative outcomes were also examined
159 eligible patients 
during study period 
(aged 60+ admitted 
under vascular 
surgeons with aortic or 
lower limb surgery or 
angioplasty proposed) 
 
21 patients with capacity to consent declined 
1 personal consultee for a patient without 
        capacity to consent declined 
Unable to identify consultee for 1 patient without 
capacity to consent 
6 missed due to logistical reasons (i.e. admitted 
and discharged over weekend when no researcher 
available) 
130 patients 
recruited 
116 completed 
MoCA 
preoperatively 
14 unable to complete 
preoperatively  (i.e. 
too unwell, delirious, 
emergency surgery 
etc) 
2 patients had no 
procedure performed 
114 patients undergoing procedures with 
preoperative MoCA score 
Fig 2. Flow chart. MoCA, Montreal Cognitive Assessment.
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age, LOS $12 days, MoCA <24, and EFS score $6.5 was
examined with the area under the receiver operating char-
acteristic curve (AUC).
Paired t-tests were used to examine the association be-
tween cognitive scores at baseline and at outpatient follow-
up in the subset of 32 patients.
RESULTS
The 114 patients were recruited and analyzed as shown
in Fig 2. The mean age of patients was 76.3 years (standard
deviation [SD], 7.36 years), and 67.5% were men. Eighty-
nine percent of participants were white British according to
the 2011 census categories. Mean length of full-time edu-
cation was 10.6 years (SD, 2.18 years).
The study recruited patients as they presented to the
vascular surgical ward and included those undergoing ma-
jor open vascular surgery, endovascular procedures, and
preoperative investigations (Table I).
Feasibility. The mean length of time taken to com-
plete the MoCA was 9 minutes 41 seconds, and feedback
from patients and their relatives followed up in the outpa-
tient subset found this test acceptable in the preoperative
setting. Thirty-two (28.1%) of the 114 patients preopera-
tively assessed with the MoCA completed the test for a
second time within 21 to 167 days after discharge; the
mean number of days from hospital discharge to follow-up
cognitive assessment was 73 days (SD, 31.4 days). Com-
parison of MoCA score preoperatively and at follow-up
showed no improvement or deterioration over time
(paired t-test, 1.073; P ¼ .292). Furthermore, the mean
MoCA score in this subset of participants assessed atfollow-up was 19.9 (SD, 5.95), showing no difference with
the 20.8 (SD, 5.16) in the whole study cohort.
Of the 114 patients who underwent a procedure and
completed the MoCA, 77 (67.5%) scored <24/30 on the
examination. The mean MoCA score was 20.8 (SD,
5.16), with a range from 6 to 30. Only nine patients
(7.9%) had any record of “dementia, cognitive impair-
ment, memory problems, or confusion” in their medical
notes or electronic hospital record and on discussion
with the patient and relatives. Thus, no cognitive issue
had been previously noted (or discussed with the
patient or family) in 88.3% of patients (68 of 77) who
scored <24 on the MoCA. In total, 60.5% of patients
(68 of 114) aged 60þ years attending the hospital for
vascular procedures had previously undiagnosed cogni-
tive impairment. Of note, alcohol consumption in this
population was low, with a mean weekly number of
alcohol units consumed of 8.6 units (SD, 18.1 units)
and the weekly median 1 unit. When dichotomized at
various cutoff values, no univariate associations were
seen with MoCA <24/30.
The incidence of impaired cognition (MoCA <24)
according to age was as follows: aged 60 to 69 years,
50.0% (12 of 24); aged 70 to 79 years, 75.5% (37 of
49); aged 80þ years, 68.3% (28 of 41).
Clinically important and statistically signiﬁcant baseline
factors (Table II) associated with MoCA <24 were
included in a multivariate logistic regression model. Inde-
pendent associations between MoCA <24 and EFS score
$6.5 (odds ratio, 8.41; P ¼ .001) and diabetes (odds ratio,
4.79; P ¼ .029) were observed (Supplementary Table I,
online only).
Table I. Surgical procedures and urgency, route, and
source of presentation to vascular surgical ward
Surgical procedures and urgency of presentation N ¼ 114, No. (%)
Type of procedure
Imaging or investigation (eg, CTA with
need for intravenous hydration and
N-acetylcysteine cover, duplex ultrasound,
angiography, bronchoscopy)
12 (10.5)
Angioplasty, thrombolysis, thrombectomy,
embolectomy
25 (21.9)
Lower limb bypass graft 18 (15.8)
EVAR 40 (35.1)
Open AAA repair 4 (3.5)
Toe or foot amputation 3 (2.6)
Below-knee or through-knee amputation 2 (1.8)
Above-knee amputation 1 (0.9)
Other (eg, carotid-subclavian bypass, false
aneurysm repair, evacuation of hematoma,
débridement)
9 (7.9)
No. of procedures performed during admission
Single procedure performed during admission 91 (79.8)
Two procedures performed during admission 2 (1.8)
Three or more procedures performed during
admission
9 (7.9)
Referral source
Elective vascular 63 (55.3)
Through emergency department 32 (28.1)
Admitted from clinic or radiology department 14 (12.3)
Transferred from other inpatient team 5 (4.4)
Local or tertiary
Local boroughs 25 (21.9)
Neighboring boroughs 46 (40.4)
Farther aﬁeld 13 (37.7)
AAA, Abdominal aortic aneurysm; CTA, computed tomography angiog-
raphy; EVAR, endovascular aneurysm repair.
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with MoCA <24. Other postoperative associations with
MoCA <24 were wound infection, infection of any type,
bowel and bladder complications (persistent maintenance
of urinary catheter without documented clinical indication,
urinary retention, constipation, and fecal incontinence),
one or more postoperative medical complications (cardiac,
respiratory, delirium, infective), and slow gait speed and
TUAG at discharge (Table III).
Table IV shows the results of multiple logistic regres-
sion modeling to examine the association between
MoCA <24 and longer LOS ($12 days). To adjust the
relationship between MoCA <24 and LOS $12 days,
signiﬁcantly associated baseline variables were included in
the models (Supplementary Table I, online only). In this
analysis, the strength of association between MoCA and
LOS was less strong.
Several univariate associations were seen between
LOS $12 days and baseline preoperative variables
(Supplementary Table II, online only) and postoperative
outcomes (Supplementary Table III, online only). Baseline
characteristics showing univariate association with longer
LOS ($12 days) were those receiving home care, emer-
gency presentation, MoCA <24, EFS score $6.5, and pre-
operative anemia. Postoperative events associated withlonger LOS in univariate analysis were composite measures
of postoperative bowel and bladder complications, postop-
erative infections, composite measure of postoperative
complications, and composite measure of functional
impairment (postoperative falls and dependent transfers at
the third postoperative day).
MoCA <24 was associated with LOS $12 days and
age by the AUC (0.621; conﬁdence interval, 0.508-
0.734; P ¼ .049). This association between MoCA <24
and LOS $12 days was strengthened with the addition
of EFS score $6.5 (AUC, 0.695; conﬁdence interval,
0.584-0.806; P ¼ .002). Table V shows the predictive abil-
ity of models examining longer LOS ($12 days) when
MoCA <24 and EFS score $6.5 are added. All analyses
were age adjusted.
DISCUSSION
This observational study of 114 patients aged 60 years
or older, undergoing elective and emergency aortic and
lower limb arterial surgical procedures, demonstrated a
signiﬁcant burden of undiagnosed cognitive impairment.
Demonstrating cognitive impairment within a high-risk
group is important for several reasons.
First, cognitive impairment may have an impact on
information provision and the process of informed consent
and shared decision making preoperatively. Preoperative
diagnosis may help clinicians more accurately describe peri-
operative risk, given that impaired cognition is associated
with adverse in-hospital outcomes9 and longer term post-
operative outcomes.34
Second, vascular cognitive impairment confers an
increased risk of postoperative delirium with its associated
consequences35,36 and longer length of hospital stay.37
The risk of postoperative delirium is not routinely
addressed in current preoperative services despite National
Institute for Health and Clinical Excellence guidance,
which endorses this approach.38 Furthermore, evidence
shows that simple interventions, such as optimizing sensory
impairments and regularly reorienting patients, can reduce
the incidence of delirium39 if the risk of delirium is proac-
tively highlighted.
Third, the National Dementia Strategy in England40
advocates early diagnosis of cognitive impairment and de-
mentia with provision of both medical investigation and
intervention and adequate support services from the start
of the illness. Whereas the merits of this approach have
been debated recently,41 this clearly has implications for a
group shown to be at high risk. For these reasons, case
ﬁnding by proactive examination of cognitive functioning
in a high-risk population seems an appropriate step in pre-
operatively assessing older vascular surgical patients.
Older age was not signiﬁcantly associated with
MoCA <24 in this population, and 50% of participants
aged 60 to 69 years scored <24 on the MoCA. Consensus
estimates of the population prevalence of dementia in the
United Kingdom suggest that only 1% of those aged 65
to 69 years have dementia.42 The high rate of cognitive
impairment seen at younger ages in this study may
Table II. Baseline preoperative variables and preoperative scores associated with Montreal Cognitive Assessment
(MoCA) score <24 (univariate associations)
Baseline characteristics
Cognition
P value
MoCA $ 24þ
(n ¼ 37)
(32.5%), No. (%)
MoCA <24
(n ¼ 77)
(67.5%), No. (%)
Age > 75 years 17 (45.9) 46 (59.7) .165a
Gender (male) 25 (67.6) 52 (67.5) .997
Marital status (married) 24 (64.9) 36 (48.0) .092
Smoking status (ever smoked) 29 (78.4) 62 (84.0) .465
#10 years full-time education 19 (52.8) 45 (59.2) .521
Hospital admission in preceding 12 months 20 (55.6) 47 (61.0) .580
Receives home care 7 (18.9) 39 (50.6) .001a
Lives alone 9 (24.3) 34 (44.2) .041
Urgency of presentation (elective) 23 (62.2) 44 (57.1) .610
On $6 medications 16 (43.2) 56 (73.7) .002a
Ischemic heart disease 11 (29.7) 36 (46.8) .084
Heart failure 2 (5.4) 11 (14.3) .217b
Atrial ﬁbrillation 7 (18.9) 21 (27.3) .332
Hypertension 28 (75.7) 60 (78.9) .694
Chronic lung disease 11 (29.7) 24 (31.2) .876
Diabetes 3 (8.1) 26 (33.8) .003a,b
Chronic kidney disease stage 3, 4, or 5 12 (32.4) 32 (41.6) .349
Cerebrovascular disease 5 (13.5) 19 (24.7) .171
Multisite vascular disease 9 (24.3) 37 (48.7) .013a
Cancer 10 (27.0) 13 (16.9) .206
Dementia/any note of cognitive issue 0 (0) 9 (11.7) .030b
Depression 6 (16.2) 13 (16.9) .929
Fall in last 6 months 9 (24.3) 24 (31.2) .451
Visual impairment (visually impaired or blind) 37 (100.0) 72 (93.5) .113
Hearing impairment 3 (8.3) 22 (28.6) .016b
Urinary incontinence 7 (18.9) 16 (20.8) .817
Fecal incontinence 5 (13.5) 6 (7.8) .333
Self-reported weight loss 14 (38.9) 39 (52.0) .195
Self-reported exhaustion 16 (43.2) 26 (33.8) .326
Preoperative grip strength (below age- or gender-matched norms) 13 (39.4) 42 (60.0) .050
Gait speed <0.6 m/s (preoperatively) 4 (14.3) 31 (59.6) <.001c
TUAG $20 seconds (preoperatively) 4 (14.3) 26 (50.0) .002c
EFS score $6.5 5 (13.9) 51 (66.2) <.001a
HADS anxiety score 8þ 8 (24.2) 14 (20.6) .676
HADS depression score 8þ 5 (15.2) 20 (29.4) .119
Preoperatively anemic (hemoglobin <13 g/dL men and 12 g/dL women) 20 (54.1) 54 (70.1) .092
EFS, Edmonton Frail Scale; HADS, Hospital Anxiety and Depression Scale; TUAG, timed up and go.
Bold values are statistically signiﬁcant at the 5% level.
aVariable included in multiple logistic regression model.
bCell count of less than 5, so Fisher exact test used in place of c2 test.
cNote different denominator because of 34 missing cases.
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and vascular dementia as opposed to other dementias, such
as Alzheimer disease, in a population with vascular risk fac-
tors, multisite vascular disease, and signiﬁcant leukoaraio-
sis.10,43 The lack of association seen between older age and
MoCA <24 may be due to the increased mortality at
younger ages of those with multiple vascular risk factors.44
The literature validating MoCA as a short assessment
tool in several different patient groups has proliferated in
the last 2 years. When the MoCA was ﬁrst described, the
authors used a cutoff score of <26/30 to deﬁne mild
cognitive impairment as validated by a neuropsychological
battery, and the MoCA showed a sensitivity of 90% and
speciﬁcity of 87%.14 For Alzheimer dementia compared
with the same neuropsychological battery, the MoCAshowed sensitivity of 100% and speciﬁcity of 87%. More
recent studies propose a cutoff value of 24/30 in patients
with cardiovascular disease and diabetes, with preserved
sensitivity and speciﬁcity compared with the Neuropsycho-
logical Assessment Battery Screening Module.20 The
MoCA was chosen for this study on clinical grounds as it
is better than the Mini-Mental State Examination in assess-
ing the executive dysfunction known to predominate in
those with vascular cognitive impairment.45,46 In terms of
accessibility, the MoCA is available in 36 languages and
validated in 21 languages, and there is a version for those
who are visually impaired. In addition, the standard
MoCA is scored according to years of education, and the
MoCA basic for those with lower educational attainment
or illiteracy is in development. This is relevant to this
Table III. Postoperative outcomes associated with Montreal Cognitive Assessment (MoCA) score <24 (univariate
associations)
Postoperative outcomes
Cognition
P value
MoCA $ 24
(n ¼ 37) (32.5%), No. (%)
MoCA <24
(n ¼ 77) (67.5%), No. (%)
Postoperative delirium 4 (10.8) 16 (20.8) .293a
Pneumonia 2 (5.4) 6 (7.8) 1.00a
Acute coronary syndrome 2 (5.4) 5 (6.5) 1.00a
Arrhythmia 2 (5.4) 6 (7.8) 1.00a
Heart failure 0 (0) 3 (3.9) .550a
Fall on ward 1 (2.7) 10 (13.0) .100a
Urinary tract infection 1 (2.7) 4 (5.2) 1.00a
Wound infection 0 (0) 15 (19.5) .002a
Catheter without clinical indication documented 1 (2.7) 10 (13.0) .100a
Urinary retention 0 (0) 5 (6.5) .172a
Constipation 3 (8.1) 7 (9.1) 1.00a
Fecal incontinence 2 (5.4) 13 (16.9) .138a
Dependent transfers postoperative day 3 8 (25.0) 27 (37.0) .230
Composite postoperative bowel and bladder complications 5 (13.5) 24 (31.2) .043b,c
Composite postoperative infective complications 3 (8.1) 23 (29.9) .009a,d
Composite postoperative complications 9 (24.3) 35 (44.2) .041b,e
Composite postoperative functional issues 13 (35.1) 34 (44.2) .360f
TUAG at discharge of $20 seconds 8 (30.8) 33 (62.3) .008g
Gait speed at discharge of <0.6 m/s 8 (30.8) 37 (71.2) .001h
In-hospital mortality 2 (5.4) 2 (2.6) .594a
LOS $12 days 5 (13.5) 25 (32.5) .031b
LOS $10 days 9 (24.3) 34 (44.2) .041
LOS, Length of stay; TUAG, timed up and go.
Bold values are statistically signiﬁcant at the 5% level.
aCell count of less than 5, so Fisher exact test used in place of c2 test.
bVariables included in multiple linear regression.
cComposite variable including postoperative catheter without clinical indication documented, urinary retention, constipation, fecal incontinence.
dComposite variable including postoperative pneumonia, urinary tract infection, wound infection.
eComposite variable including postoperative delirium, pneumonia, acute coronary syndrome, arrhythmia, heart failure, urinary tract infection, wound
infection.
fComposite variable including fall on ward and dependent transfers at postoperative day 3.
gNote different denominator because of 36 missing cases.
hNote different denominator because of 35 missing cases.
Table IV. Postoperative outcomes associated with Montreal Cognitive Assessment (MoCA) score <24 adjusted for
signiﬁcant baseline associations and age
Postoperative outcomes associated with MoCA <24
adjusted for signiﬁcant baseline associations Adjusted odds ratio 95% Conﬁdence interval P value
Age >75 years 2.99 1.01-8.89 .049
Diabetes 5.89 1.36-25.58 .018
EFS score $6.5 12.55 3.83-41.15 <.001
Composite postoperative bowel and bladder complications 4.32 0.96-19.50 .057
Composite postoperative complications 1.53 0.47-4.97 .484
LOS $12 days 1.05 0.25-4.38 .950
EFS, Edmonton Frail Scale; LOS, length of stay.
Bold values are statistically signiﬁcant at the 5% level.
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time education was just 10.4 years (SD, 2.29 years).
Strong associations were seen between MoCA <24
and EFS score $6.5. In combination, these measures
of impaired cognition and frailty were more strongly pre-
dictive of longer LOS than they were separately. This is
not surprising, given our knowledge about the coexis-
tence of geriatric syndromes47,48 and the causative roleof vascular risk factors in frailty, vascular cognitive
impairment, and vascular dementia.49 The strength of
the relationship between longer LOS (>12 days) and
MoCA <24 and EFS score $6.5 is particularly relevant
clinically where preoperative identiﬁcation of vascular
cognitive impairment, dementia, and frailty may facili-
tate perioperative risk prediction and optimization to
modify this risk.
Table V. Areaunder receiver operating characteristic curve
(AUC) by predictor of longer hospital stay (LOS$12 days)
Adjustment AUC
95% Conﬁdence
interval P value
Age >75 years and
MoCA <24
0.621 0.508-0.734 .049
Age >75 years and EFS
score $6.5
0.660 0.541-0.779 .010
Age >75 years, MoCA <24,
and EFS $6.5
0.695 0.584-0.806 .002
EFS, Edmonton Frail Scale; LOS, length of stay;MoCA,Montreal Cognitive
Assessment.
Bold values are statistically signiﬁcant at the 5% level.
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enced by several factors. Whereas cognitive impairment
was frequently observed with MoCA, this was not
compared with a neurocognitive battery or a memory
clinic diagnosis of vascular cognitive impairment or de-
mentia. MoCA has, however, been validated against neuro-
cognitive assessment in previous work,50 particularly in
patients after stroke, who have proﬁles of vascular risk
similar to those of the surgical population in this study.
The 2- to 3-month follow-up MoCA evaluation was
potentially biased as ﬁtter patients or those with less cogni-
tive impairment are more likely to attend follow-up appoint-
ments, and those with more complex surgical needs may be
preferentially invited back as outpatients. However, analysis
of this small subset was representative of the overall sample
in terms of other baseline characteristics. The study observa-
tion that preoperative cognitive impairment remained stable
at 2- to 3-month follow-up may support the accuracy of
MoCA as a preoperative cognitive assessment tool, albeit
with the acknowledgment that use of a convenience sample
can introduce systemic bias. This conclusion could therefore
not be extrapolated to the whole study population.
Whereas all attempts were made to perform the preop-
erative cognitive assessment without interruption, both the
physical environment and the concern from patients
regarding impending surgery may potentially affect cognitive
test results. However, the follow-up cognitive assessments
were performed in a quiet room in the outpatient setting
without interruption or operation-related anxiety, with
similar case-by-case results. Again, the likely systematic bias
from the sampling method should be acknowledged here.
Exclusion of potential participants admitted and dis-
charged over the weekend also introduces potential sam-
pling bias in the whole study cohort. Consecutive
patients were eligible for participation, however, and it is
very rare for older vascular surgical patients to be admitted
and discharged in such a short time frame.
As expected, LOS data were skewed. Whereas there are
inherent issues with use of skewed data, the mean value of
12 days was deemed to be clinically pertinent as it is closely
associated with considerable resource use.
Finally, although the study showed a 20% incidence of
postoperative delirium, this may be an underestimationbecause of the ﬂuctuant nature of the condition and the
single researcher performing the Confusion Assessment
Method once daily on weekdays only. The lack of statistical
association seen between postoperative delirium and pre-
operative cognitive impairment in this work is surprising.
It is probable that this is due in part to a mixed cohort of
surgical procedures included in the study. For example,
although the underlying vascular risk factors are compara-
ble between patients and therefore make the presence of
cognitive impairment equally likely between participants,
patients undergoing relatively minor procedures, such as
angioplasty, are at lower risk of postoperative delirium
than those undergoing open abdominal aortic aneurysm
repair. The lack of association between postoperative
delirium and cognitive impairment is therefore likely to
represent a type II error.
CONCLUSIONS
The frequency of vascular risk factors in older vascular
surgical patients and the high prevalence of previously unrec-
ognized cognitive impairment demonstrated in this observa-
tional study suggest that preoperative examination for
cognitive impairment should be incorporated into standard
preoperative assessment of at-risk patients. The MoCA was
a clinically feasible tool for preoperative use in both elective
and emergency surgical patients. Establishing the MoCA in
routine preoperative pathways could promote considered
handling of consent and capacity; proactive identiﬁcation
and modiﬁcation of delirium risk; and examination of under-
lying causes for cognitive decline, risk factor management,
and early onward referral to specialist memory services.
The strong association between cognitive impairment
and frailty may be clinically useful in highlighting potential
areas for preoperative modiﬁcation of risk to reduce adverse
postoperative outcomes, including prolonged LOS. Future
research should examine the feasibility and impact of pre-
operative services that incorporate cognitive assessment
and optimization and provision of information to older
patients into routine care pathways.
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Supplementary Table I (online only). Baseline
characteristics independently associated with Montreal
Cognitive Assessment (MoCA) score <24/30
Baseline variables
associated with MoCA <24a
Adjusted
odds ratio
95% Conﬁdence
interval P value
Age >75 years 1.85 0.67-5.12 .239
Home care 1.12 0.35-4.09 .785
Medications 6þ 1.25 0.45-3.49 .676
Multisite vascular disease 2.02 0.71-5.74 .185
Diabetes 4.78 1.17-19.53 .029
EFS score $6.5 8.41 2.38-29.70 .001
EFS, Edmonton Frail Scale.
Bold values are statistically signiﬁcant at the 5% level.
aHearing impairment and gait speed and timed up and go, although
signiﬁcantly associated with MoCA <24 in the univariate associations, were
not included in this model because of a low number of cases and missing
data, respectively.
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Supplementary Table II (online only). Preoperative factors associated with length of stay (LOS) $12 days (univariate
analyses)
Baseline characteristics
LOS
P value
LOS < 12 days
(n ¼ 84) (73.7%),
No. (%)
LOS $ 12 days
(n ¼ 30) (26.3%),
No. (%)
Age >75 years 45 (53.6) 18 (60.0) .543
Gender (male) 60 (71.4) 17 (56.7) .138
Marital status (married) 47 (56.6) 13 (44.8) .273
Smoking status (ever smoked) 66 (79.5) 26 (89.7) .220
Had #10 years full-time education 49 (59.8) 15 (50.0) .356
Admitted to hospital in last 12 months 48 (57.1) 19 (65.5) .429
Has home care 27 (32.1) 19 (63.3) .003
Lives alone 29 (34.5) 14 (46.7) .239
Urgency of presentation (elective) 59 (70.2) 8 (26.7) <.001
On 6þ medications 49 (58.3) 23 (79.3) .043
Ischemic heart disease 33 (39.3) 14 (46.7) .481
Heart failure 6 (7.1) 7 (23.3) .017
Atrial ﬁbrillation 19 (22.6) 9 (30.0) .420
Hypertension 67 (79.8) 21 (72.4) .411
Chronic lung disease 23 (27.4) 12 (40.0) .198
Diabetes 19 (22.6) 10 (33.3) .247
Chronic kidney disease stage 3A or worse 31 (36.9) 13 (43.3) .535
Cerebrovascular disease (previous stroke or transient ischemic attack) 19 (22.6) 5 (16.7) .492
Multisite vascular disease 30 (35.7) 16 (55.2) .066
Cancer 19 (22.6) 4 (13.3) .277
Dementia or cognitive issues 6 (7.1) 3 (10.0) .618a
History of depression documented 16 (19.0) 3 (10.0) .254a
Fall in last 6 months 25 (29.8) 8 (26.7) .748
Visual impairment (visually impaired or blind) 82 (97.6) 27 (90.0) .080
Hearing impairment 13 (15.7) 12 (40.0) .006
Self-reported weight loss 31 (37.8) 22 (75.9) <.001b
Self-reported exhaustion 30 (35.7) 12 (40.0) .676
Urinary incontinence 15 (17.9) 8 (26.2) .302
Fecal incontinence 10 (11.9) 1 (3.3) .172a
Preoperative grip strength (below age- or gender-matched norms) 38 (48.7) 17 (68.0) .093c
MoCA <24 52 (61.9) 25 (83.3) .031
TUAG $ 20 seconds 21 (33.3) 9 (52.9) .138d
Gait speed <0.6 m/s 23 (36.5) 12 (70.6) .012d
EFS score $6.5 35 (41.7) 21 (72.4) .004e
HADS anxiety score 8þ 17 (22.4) 5 (20.0) .803f
HADS depression score 8þ 15 (19.7) 10 (40.0) .042f
Preoperatively anemic (hemoglobin <13 g/dL men and 12 g/dL women) 49 (58.3) 25 (83.3) .014
EFS, Edmonton Frail Scale; HADS, Hospital Anxiety and Depression Scale; MoCA, Montreal Cognitive Assessment; TUAG, timed up and go.
Bold values are statistically signiﬁcant at the 5% level.
aCell count of less than 5, so Fisher exact test used in place of c2 test.
bNote different denominator because of three missing cases.
cNote different denominator because of 11 missing cases.
dNote different denominator because of 34 missing cases.
eNote different denominator because of one missing case.
fNote different denominator because of 13 missing cases.
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Supplementary Table III (online only). Postoperative outcomes associated with length of stay (LOS) $12 days
(univariate analyses)
Postoperative outcomes
LOS
P value
LOS < 12 days
(n ¼ 84) (73.7%), No. (%)
LOS $ 12 days
(n ¼ 30) (26.3%), No. (%)
Postoperative delirium 10 (11.9) 10 (33.3) .008
Pneumonia 3 (3.6) 5 (16.7) .029a
Acute coronary syndrome 3 (3.6) 4 (13.3) .077a
Arrhythmia 4 (4.8) 4 (13.3) .204a
Heart failure 0 (0) 3 (10.0) .017a
Fall on ward 5 (6.0) 6 (20.0) .025
Dependent transfers postoperative day 3 11 (14.5) 24 (82.8) <.001
Urinary tract infection 2 (2.4) 3 (10.0) .113a
Wound infection 5 (6.0) 10 (33.3) <.001
Catheter without clinical indication documented 3 (3.6) 8 (26.7) .001a
Urinary retention 4 (4.8) 1 (3.3) 1.000a
Constipation 6 (7.1) 4 (13.3) .451a
Fecal incontinence 3 (3.6) 12 (40.0) <.001a
Composite postoperative bowel and bladder complications 12 (14.3) 17 (56.7) <.001
Composite postoperative infective complications 10 (11.9) 16 (53.3) <.001
Composite postoperative complications 22 (26.2) 21 (70.0) <.001
Composite adverse postoperative functional outcomes 22 (26.2) 25 (83.3) <.001
Discharge TUAG $20 seconds 25 (41.0) 16 (88.9) <.001b
Discharge gait speed <0.6 m/s 28 (45.9) 17 (100.0) <.001c
In-hospital mortality 0 (0) 4 (13.3) .004a
TUAG, Timed up and go.
Bold values are statistically signiﬁcant at the 5% level.
aCell count of less than 5, so Fisher exact test used in place of c2 test.
bNote different denominator because of 35 missing cases.
cNote different denominator because of 36 missing cases.
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